Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherBasic Science (Animal or Phantoms)

Synthesis and Preclinical Evaluation of 18F-labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation

Miho Shukuri, Aya Mawatari, Shuhei Takatani, Tsuyoshi Tahara, Michiko Inoue, Wakiko Arakaki, Masahiro Ohno, Hisashi Doi and Hirotaka Onoe
Journal of Nuclear Medicine March 2022, jnumed.121.263713; DOI: https://doi.org/10.2967/jnumed.121.263713
Miho Shukuri
1 Showa Pharmaceutical University, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aya Mawatari
2 Laboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuhei Takatani
2 Laboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuyoshi Tahara
3 Department of in vivo Imaging, Advanced Research Promotion Center, Tokushima University, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiko Inoue
4 Laboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wakiko Arakaki
2 Laboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiro Ohno
5 Laboratory for Brain Connectomics Imaging, RIKEN Center for Biosystems Dynamics Research, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisashi Doi
2 Laboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirotaka Onoe
6 Human Brain Research Center, Graduate School of Medicine, Kyoto University, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Cyclooxygenase (COX) is a rate-limiting enzyme in the synthesis of pro-inflammatory prostanoids from arachidonic acid. In vivo imaging of COX by positron emission tomography (PET) is a potentially powerful tool for assessing the inflammatory response to injury, infection, and disease. We previously reported on a promising PET probe for COX imaging, 11C-labeled ketoprofen methyl ester, which can detect COX-1 activation in models of neuroinflammation and neurodegenerative disorders. In the current study, we aimed to design a fluorine-substituted benzoyl group of ketoprofen (FKTP) and to evaluate its racemate and enantiomers (18F-labeled ketoprofen methyl ester [18F]FKTP-Me) as PET pro-radiotracers, potential radiopharmaceuticals for in vivo PET study of COX-1. Methods: We performed nucleophilic aromatic 18F-fluorination in order to obtain the desired racemic radiolabeled probe (RS)-[18F]FKTP-Me at a radiochemical yield of 11–13%. Subsequent high performance liquid chromatography separation with a chiral column yielded the desired enantiomerically pure (R)- and (S)-[18F]FKTP-Me. We examined the in vivo properties of (RS)-, (R)-, and (S)-[18F]FKTP-Me in PET studies using rats in which hemispheric inflammation was induced by intrastriatally injecting a lipopolysaccharide. Results: Racemic (RS)-[18F]FKTP-Me and enantiomeric (R)- or (S)-[18F]FKTP-Me were synthesized with radiochemical and chemical purities of >99%. The metabolite analysis revealed that the racemic (RS)-[18F]FKTP-Me crossed the blood-brain barrier and entered the brain, where it was subsequently hydrolyzed to its pharmacologically active acid form. PET images revealed a high accumulation of (R)-, (S)-, and (RS)-[18F]FKTP in the inflamed regions in rat brain. Moreover, the accumulated radioactivity of (S)-[18F]FKTP-Me was higher than that of (RS)-[18F]FKTP-Me and (R)-[18F]FKTP-Me, which was correlated with the stereospecific inhibitory activity of FKTP against COX-1. Conclusion: Based on the results of this study, we conclude that racemic (RS)-[18F]FKTP-Me and its enantiomers could act as pro-radiotracers of neuroinflammation in rat brain by the association of their hydrolyzed acid forms with COX-1 in inflamed regions. In particular, (S)-[18F]FKTP-Me demonstrated suitable properties as a COX-1-specific probe in PET imaging of neuroinflammation.

  • Animal Imaging
  • Molecular Imaging
  • Radiopharmaceuticals
  • <sup>18</sup>F-FKTP-Me
  • COX-1
  • PET
  • neuroinflammation
  • Copyright © 2022 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and Preclinical Evaluation of 18F-labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and Preclinical Evaluation of 18F-labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation
Miho Shukuri, Aya Mawatari, Shuhei Takatani, Tsuyoshi Tahara, Michiko Inoue, Wakiko Arakaki, Masahiro Ohno, Hisashi Doi, Hirotaka Onoe
Journal of Nuclear Medicine Mar 2022, jnumed.121.263713; DOI: 10.2967/jnumed.121.263713

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and Preclinical Evaluation of 18F-labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation
Miho Shukuri, Aya Mawatari, Shuhei Takatani, Tsuyoshi Tahara, Michiko Inoue, Wakiko Arakaki, Masahiro Ohno, Hisashi Doi, Hirotaka Onoe
Journal of Nuclear Medicine Mar 2022, jnumed.121.263713; DOI: 10.2967/jnumed.121.263713
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Basic Science (Animal or Phantoms)

  • CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
  • Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model
Show more Basic Science (Animal or Phantoms)

Basic (Molecular Imaging: Animal Imaging)

  • Administration routes for SSTR- / PSMA- and FAP-directed theranostic radioligands in mice
  • TRACKING INNATE IMMUNE ACTIVATION IN A MOUSE MODEL OF PARKINSON’S DISEASE USING TREM1 AND TSPO PET TRACERS
Show more Basic (Molecular Imaging: Animal Imaging)

Similar Articles

Keywords

  • Animal Imaging
  • molecular imaging
  • Radiopharmaceuticals
  • <sup>18</sup>F-FKTP-Me
  • COX-1
  • PET
  • neuroinflammation
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire